Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) in Pulpotomies Primary Teeth

Launched by HADASSAH MEDICAL ORGANIZATION · Jul 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a new treatment called Neo-Putty® in children who need a procedure known as pulpotomy on their primary molars, which are the baby teeth. A pulpotomy is done when the pulp, the soft tissue inside the tooth, is infected or damaged, usually due to cavities. The trial compares Neo-Putty® to a traditional treatment called Formocresol (FC) to see which works better in helping the teeth heal.

To be eligible for this trial, children must be between 2 and 10 years old and have primary teeth that need a pulpotomy. However, children who are not in good health or whose teeth require a more extensive treatment called pulpectomy cannot participate. If enrolled, participants can expect to undergo the pulpotomy with either Neo-Putty® or Formocresol, and researchers will follow up to see how well each treatment works. This study is currently active but not recruiting new participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • primary teeth which requires pulpotomy.
• Exclusion Criteria:
• • not healthy patients,
• • teeth which requires pulpectomy.